Anondita Medicare Reports Robust H1 FY27 Results with 69% PAT Growth
Anondita Medicare Ltd · Press Release · 16 Nov 2026, 7:20 pm
Anondita Medicare Reports Robust H1 FY27 Results with 69% PAT Growth Anondita Medicare announced its consolidated financial results for the half year ended 30th Sep'26 (H1 FY27), delivering a 35.94% YoY increase in revenue from operations to ₹7,354.17 lakhs from ₹5,409.70 lakhs in H1 FY26. EBITDA surged 69.81% YoY to ₹3,329.80 lakhs, expanding EBITDA margin by 903 bps to 45.28%. Profit after tax climbed 69.04% YoY to ₹2,200.60 lakhs, with PAT margin rising 586 bps to 29.92%. Growth was supported by ongoing capacity expansions, product diversification, and distribution reach across male and patented female condom segments.
Original exchange filing (PDF)
More announcements from Anondita Medicare Ltd
- Anondita Medicare Limited has informed the Exchange about Link of Recording and Outcome of Earning Call · 17 Nov 2026
- Anondita Medicare Limited has informed the Exchange regarding Submission of Monitoring Agency Report for half year ended September 30, 2026'. · 15 Nov 2026
- Anondita Medicare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 15 Nov 2026
- Anondita Medicare Limited has informed the Exchange regarding ' Integrated Standalone and Consolidated Financial Result for half year ended September 30, 2026'. · 15 Nov 2026
- Anondita Medicare Limited has informed the Exchange regarding 'Financial Result for half year ended September 30, 2026'. · 15 Nov 2026
- Anondita Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- Anondita Medicare Limited has informed the Exchange about Schedule of meet for H1 FY 2027 Earnings Call · 16 Nov 2026
- Anondita Medicare Limited has informed the Exchange regarding a press release dated November 06, 2026, titled "Anondita Medicare Secures Two CMSS Purchase Orders for Supply of Over 9.80 Crore Condoms ". · 06 Nov 2026
